LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS
LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS
批准号:
2077491
负责人:
Mary C Nakamura
金额:
$7.61万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-01 至 1999-06-30
关键词:
CHO cells SDS polyacrylamide gel electrophoresis affinity chromatography autoradiography cell adhesion cell cell interaction cell mediated cytotoxicity chimeric proteins cytolysis flow cytometry glycoproteins human subject ion exchange chromatography laboratory rat ligands membrane proteins natural killer cells nucleic acid sequence plaque assay receptor binding transfection western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Natural killer (NK) cells are able to specifically recognize and lyse
certain tumor or virally-infected cells without prior sensitization to
targets. The cell surface molecules responsible for the specificity of
the NK-target cell interaction are not defined. Recent structural and
functional evidence suggests that the cell surface glycoprotein NKR-P1 on
rat NK cells may serve as an important receptor in the recognition of
target cells. The identification of ligands on target cells which bind to
NKR-P1 will help to define the mechanisms underlying the NK cell response.
NKR-P1 is a type II integral membrane protein with an extracellular C-type
lectin domain. The lectin region is structurally similar to known
receptor molecules. Our laboratory has generated a mutant rat NK cell line
(derived from RNK- 16) lacking expression of NKR-P1, which is selectively
unable to lyse certain target cells derived from C57BL/6 (H-2b) mice.
Other target cell lines are killed equally by mutant and wild type RNK-16
cells. These results support the hypothesis that NKR-P1 may be required
for recognition and/or lysis of some but not all target cells.
My proposed studies will focus on defining the ligand(s) for NKR-P1 on
target cells. I have prepared a recombinant soluble chimeric protein
composed of the extracellular domain of NKR-P1 fused to the Fc portion of
human IgG1 (rNKR-P1/Fc). Utilizing this chimeric protein as a probe for
ligand, target cells will be screened by FACS, by cell binding to
immobilized chimeric protein, and by antibody-dependent cell mediated
cytotoxicity. To demonstrate that target cell interactions with soluble
chimeric rNKR-P1/Fc are analogous to cell surface protein interactions,
CHO cells, transfected to express high levels of cell surface NKR-P1, will
be used to examine specific cell-cell adhesion to targets. Ligand(s) for
NKR-P1 will be affinity-purified from appropriate target cells using
immobilized rNKR-P1/Fc. Putative ligand(s) will be characterized with
regard to size, susceptibility to proteolysis, carbohydrate content, and
relation to known cell-surface molecules.
These studies will identify ligand(s) for NKR-P1, a proposed receptor on
NK cells. Identification of the molecules involved in the specificity of
NK-target cell recognition will provide important insight into the role of
NK cells in immune regulation and how they might discriminate between
tumors and non-neoplastic cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY
-
批准号:10469673
-
项目类别:
-
资助金额:$80.74万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
Administrative Core
-
批准号:10469674
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
Administrative Core
-
批准号:10281471
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY
-
批准号:10685559
-
项目类别:
-
资助金额:$80.74万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY
-
批准号:10281470
-
项目类别:
-
资助金额:$80.74万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
Administrative Core
-
批准号:10685560
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
Resource-based Center for the Advancement of Precision Medicine in Rheumatology
-
批准号:10007596
-
项目类别:
-
资助金额:$72.17万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
DAP12 and ITAM-signals in Osteoclastogenesis
-
批准号:8397538
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Mary C Nakamura
-
依托单位:
DAP12 and ITAM-signals in Osteoclastogenesis
-
批准号:7797802
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Mary C Nakamura
-
依托单位:
DAP12 and ITAM-signals in Osteoclastogenesis
-
批准号:8195894
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Mary C Nakamura
-
依托单位:
DAP12 and ITAM-signals in Osteoclastogenesis
-
批准号:7906050
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Mary C Nakamura
-
依托单位:
Using VEGF expression in inflammatory arthritis to induce targeted apoptosis
-
批准号:7667470
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2008
-
负责人:Mary C Nakamura
-
依托单位:
Using VEGF expression in inflammatory arthritis to induce targeted apoptosis
-
批准号:7509772
-
项目类别:
-
资助金额:$17.09万
-
财政年份:2008
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:6819863
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:7281156
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:7476480
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:7114316
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:6929003
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS
-
批准号:2732785
-
项目类别:
-
资助金额:$8.91万
-
财政年份:1994
-
负责人:Mary C Nakamura
-
依托单位:
LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS
-
批准号:2077492
-
项目类别:
-
资助金额:$7.67万
-
财政年份:1994
-
负责人:Mary C Nakamura
-
依托单位: